Earlyfit launched India’s first doctor-led GLP-1 weight loss program, led by a team of SeniorEndocrinologists

New Delhi, India  | August , 2025 :  With the recent launch of GLP1 medications like Ozempic (Wegovy) and Mounjaro in India, it is more important than ever for people to receive the right guidance and access to safe and evidence-based care. At a time when confusion is high and unregulated options are widespread, Indians deserve clarity and confidence in managing their health. This belief drives Earlyfit, a health tech startup, that is reimagining how India addresses obesity and related conditions such as diabetes, PCOS and obstructive sleep apnea.

Earlyfit is now running India’s first doctor-led GLP1 weight loss program that helps Indians lose up to 20% of their weight. It combines supervised access to medications like semaglutide and tirzepatide with structured follow-up, regular lab testing, personalized nutrition coaching, exercise support and app-based tracking to help people lose weight safely and sustainably.

The program has been designed by Dr. Saptarshi Bhattacharya, Senior Consultant Endocrinologist at Indraprastha Apollo Hospitals and Chief Medical Advisor at Earlyfit, along with Dr Ankita Aneja, an experienced endocrinologist who has worked at Safdarjung Hospital, Ganga Ram Hospital and RML Hospital, and Dr Savita Jain, an endocrinologist trained at Indraprastha Apollo Hospitals Delhi, DMC Ludhiana and Mohan Dai Oswal Hospital.

Right combination of efficacy, safety and sustainability

The program includes:

• Holistic care with regular medical consults with endocrinologists – doctors super-specialized (DM/DrNB) in diabetes, obesity and hormonal diseases
• One-on-one nutrition and lifestyle coaching to keep one accountable
• At-home diagnostics (assessing 35 biomarkers), in partnership with Pharmeasy Labs and Healthians
• Progress tracking via the EarlyFit app – Meal logging, Apple/Google watch integration and Smart scale shipped to customers
• Prescription-based GLP-1 medications, in partnership with Medkart
• Comprehensive side effect management support
• Fully virtual care for convenience and access to all

The EarlyFit program prioritizes effectiveness and safety . EarlyFit integrates structured lifestyle changes, including a protein-rich nutrition plan and physical activity which not only support fat loss while preserving muscle mass but also help sustain weight loss even after discontinuing the GLP-1 medication.

India’s growing need for medical weight loss

Over 130 million Indians are currently overweight or obese, according to recent NFHS and ICMR data. Urban as well as rural India is also seeing a sharp rise in hormonal and metabolic disorders, such as PCOS, diabetes, fatty liver disease, cholesterol problems and heart attacks. Yet, access to structured, medically guided weight loss programs remains limited, leaving many without the right support or information.

About Earlyfit

Founded in 2025, Earlyfit is a metabolic health platform offering doctor-prescribed GLP-1 therapy combined with diagnostics, coaching, and smart tracking tools. The platform is designed to treat obesity in a safe, effective and sustainable manner. Led by endocrinologists, nutritionists, and coaches, Earlyfit is currently available across India and expanding rapidly.

Earlyfit launches a weight loss program focused on long-term health and sustainable weight loss.

August XX, 2025 | New Delhi, India – In today’s space that’s crowded with fad diets, fitness fads, and social media detoxes, Earlyfit is reimagining what sustainable weight loss can look like, with the guidance of doctors, GLP-1 medication, and a deep focus on metabolic health.

Earlyfit recently announced the official launch of its health and wellness platform, an endocrinologist-supervised program that combines medical expertise, smart technology, and nutritionist guidance to help individuals achieve lasting results. The program is designed around GLP-1 medications such as semaglutide and tirzepatide.

‘We’re not here to offer another weight loss app,’ said a spokesperson for Earlyfit. ‘We’re offering a long-term, doctor supported program, that meets people where they are, with the tools, tracking, and support they need to succeed.’

Personalised from the start

The Earlyfit journey begins with a diagnostic test and one-on-one consultation with their certified care team. This initial conversation helps determine whether GLP-1 therapy is appropriate, and sets the foundation for a deeply personalised plan tailored to each user’s health goals, metabolism, and lifestyle.

Once enrolled, users receive a smart scale, access to at-home lab testing (covering 35+ biomarkers), and full access to the Early app. The platform allows users to track progress, consult with their care team, sync wearables, and follow their customized plan.

A program that evolves

Earlyfit adapts continuously, unlike other plans. Medication dosage, nutrition, and movement plans are reviewed and updated regularly on the basis of lab results, body composition, and energy levels. Each component is guided by medical data and supervised by a certified endocrinologist.

A focus on lasting impact

One of Earlyfit’s most defining features is its commitment to long-term health. As users reach desired milestones, GLP-1 medication is gradually tapered off, helping the body reset to a healthier set point. The app continues to support users providing structured guidance.

‘Our goal isn’t just weight loss. It’s a metabolic reset, a complete change in how people understand and manage their health,’ the spokesperson added.

Real People. Real Results.

GLP-1 medications have already shown transformative outcomes in millions worldwide,users reporting weight loss of up to 20% of their body weight, much more than what diet and exercise alone typically achieve. Users also report increased energy, improved mood, and a renewed sense of control over their health.

About Earlyfit

Earlyfit is a science-led metabolic health platform offering doctor-supervised weight loss programs powered by GLP-1 therapy, smart diagnostics, and personalised care. Built in collaboration with India’s leading endocrinologists and technology experts, Earlyfit aims to make safe, sustainable weight loss accessible to all, through evidence, not extremes.

The post Earlyfit launched India’s first doctor-led GLP-1 weight loss program, led by a team of SeniorEndocrinologists first appeared on HindustanMetro.com.